IAWG members are addressing sexual and reproductive rights during COVID-19 humanitarian response. Read More>>

Unit 5: Uterine Evacuation with Medical Methods

Overview

This unit explains recommended mifepristone and/or misoprostol regimens, the essential information to provide, and the expected effects, side effects, and warning signs of uterine evacuation with mifepristone and/or misoprostol. Additionally, it describes the potential complications of uterine evacuation with mifepristone and/or misoprostol and complications management as well as post-procedure care and follow-up.

Objectives

By the end of this unit, participants will:

  • Explain recommended mifepristone and/or misoprostol regimens.
  • Explain the essential information to be given to women having uterine evacuation with mifepristone and/or misoprostol.
  • Explain the expected effects, side effects, and warning signs of uterine evacuation with mifepristone and/or misoprostol.
  • Describe potential complications of uterine evacuation with mifepristone and/or misoprostol and complications management.
  • Describe post-procedure care and follow-up for uterine evacuation with mifepristone and/or misoprostol.

Timing & Methodology

Total: 105 minutes (1 hour, 45 minutes)

  • 30 minutes: Facilitator Presentation and Group Discussion
  • 60 minutes: Demonstration and Role Plays
  • 15 minutes: Facilitator Presentation and Group Discussion

Preparation

  • Print, download, and gather materials
  • Prepare flip chart pages for the “Identifying and Managing Complications of Uterine Evacuation with Medications” activity

Resources Available Online

Sexual and reproductive health services remain critical during COVID-19

IAWG members and partners are producing clinical and programmatic guidance, assessments, policy papers, and statements to ensure continued prioritization of sexual and reproductive health and rights throughout COVID-19 response in humanitarian settings.